Roche is set to strengthen its global leadership position in oncology and to expand in therapeutic areas such as metabolism, inflammation and diseases of the central nervous system.
136418
Roche to strengthen global leadership position in oncology, to expand therapeutic areas
49489
Pfizer arthritis drug meets main goals of trial
40508
The ovarian cancer drug market will more than triple over the next decade, increasing from $460 million in 2011 to $1.4 billion in 2021
85963
Skin cancer 'a growing problem'
112868
Bone cancer research Trust calls for new treatments for bone cancer
85395
Pharmaxis appoints new chief executive
59485
Consortium supports next generation drug discovery
80049
Study impacts ovarian cancer treatment
144293
Genzyme moves to strengthen defenses against Icahn
166059
Scientists discover how to improve immune response to cancer
95241
Common cancer drugs may offer treatment for type 1 diabetes
94470
Thousands of cancer patients to benefit from new drug
12617
Alchemia to spin off oncology business
128363
Core committee will be expanded soon:
92657
Roche boosts offer for Genentech
91247
Muscle function may be enhanced by boosting brain chemical
156148
Construction on the oncology centre to begin